13F HOLDINGS REPORT
Camber Capital Management LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001654954-25-009644
Total Value
$1.07B
Positions
25
Other Managers
0
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 500,000 | $308.9M | 29.00% |
| 2 | ZIMMER BIOMET HOLDINGS INC | ZBH | 1,000,000 | $91.2M | 8.56% |
| 3 | BAXTER INTL INC | 071813109 | 2,850,000 | $86.3M | 8.10% |
| 4 | HUMANA INC | HUM | 300,000 | $73.3M | 6.89% |
| 5 | CVS HEALTH CORP | CVS | 1,050,000 | $72.4M | 6.80% |
| 6 | GLOBUS MED INC | GMED | 800,000 | $47.2M | 4.43% |
| 7 | ICON PLC | ICLR | 300,000 | $43.6M | 4.10% |
| 8 | ASCENDIS PHARMA A/S | ASND | 250,000 | $43.1M | 4.05% |
| 9 | MERCK & CO INC | MRK | 500,000 | $39.6M | 3.72% |
| 10 | GSK PLC | GLAXF | 1,000,000 | $38.4M | 3.60% |
| 11 | PFIZER INC | PFE | 1,500,000 | $36.4M | 3.41% |
| 12 | BIOMARIN PHARMACEUTICAL INC | BMRN | 600,000 | $33.0M | 3.10% |
| 13 | UNITEDHEALTH GROUP INC | UNH | 100,000 | $31.2M | 2.93% |
| 14 | VIATRIS INC | VTRS | 2,750,000 | $24.6M | 2.31% |
| 15 | BROOKDALE SR LIVING INC | 112463104 | 2,150,000 | $15.0M | 1.40% |
| 16 | ZIMVIE INC | 98888T107 | 1,600,000 | $15.0M | 1.40% |
| 17 | APELLIS PHARMACEUTICALS INC | APLS | 850,000 | $14.7M | 1.38% |
| 18 | MYRIAD GENETICS INC | MYGN | 2,000,000 | $10.6M | 1.00% |
| 19 | EVOLENT HEALTH INC | EVH | 850,000 | $9.6M | 0.90% |
| 20 | CONCENTRA GROUP HOLDINGS PAR | CON | 400,000 | $8.2M | 0.77% |
| 21 | INOGEN INC | INGN | 975,000 | $6.9M | 0.64% |
| 22 | DENALI THERAPEUTICS INC | DNLI | 400,000 | $5.6M | 0.53% |
| 23 | THERAVANCE BIOPHARMA INC | TBPH | 450,000 | $5.0M | 0.47% |
| 24 | ANAPTYSBIO INC | ANABV | 125,000 | $2.8M | 0.26% |
| 25 | ORASURE TECHNOLOGIES INC | OSUR | 900,000 | $2.7M | 0.25% |